138 related articles for article (PubMed ID: 9021916)
1. Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells.
Manickan E; Kanangat S; Rouse RJ; Yu Z; Rouse BT
J Leukoc Biol; 1997 Feb; 61(2):125-32. PubMed ID: 9021916
[TBL] [Abstract][Full Text] [Related]
2. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
[TBL] [Abstract][Full Text] [Related]
3. Immunization with dendritic cell-based DNA vaccine pRSC-NLDC145.gD-IL21 protects mice against herpes simplex virus keratitis.
Tang R; Zhai Y; Dong L; Malla T; Hu K
Immunotherapy; 2018 Mar; 10(3):189-200. PubMed ID: 29370719
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant.
Zhu M; Xu X; Liu H; Liu X; Wang S; Dong F; Yang B; Song G
J Med Microbiol; 2003 Mar; 52(Pt 3):223-228. PubMed ID: 12621087
[TBL] [Abstract][Full Text] [Related]
5. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
6. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins.
Rouse RJ; Nair SK; Lydy SL; Bowen JC; Rouse BT
J Virol; 1994 Sep; 68(9):5685-9. PubMed ID: 8057449
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
Bettahi I; Zhang X; Afifi RE; BenMohamed L
Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
[TBL] [Abstract][Full Text] [Related]
8. Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.
Eo SK; Lee S; Chun S; Rouse BT
J Virol; 2001 Jan; 75(2):569-78. PubMed ID: 11134269
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of apoptotic and anti-apoptotic genes on efficacy of DNA vaccine encoding glycoprotein B of Herpes Simplex Virus type 1.
Parsania M; Bamdad T; Hassan ZM; Kheirandish M; Pouriayevali MH; Sari RD; Jamali A
Immunol Lett; 2010 Feb; 128(2):137-42. PubMed ID: 20026118
[TBL] [Abstract][Full Text] [Related]
10. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
[TBL] [Abstract][Full Text] [Related]
11. A recombinant plasmid containing CpG motifs as a novel vaccine adjuvant for immune protection against herpes simplex virus 2.
He Z; Xu J; Tao W; Fu T; He F; Hu R; Jia L; Hong Y
Mol Med Rep; 2016 Aug; 14(2):1823-8. PubMed ID: 27357208
[TBL] [Abstract][Full Text] [Related]
12. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity.
Zhu X; Ramos TV; Gras-Masse H; Kaplan BE; BenMohamed L
Eur J Immunol; 2004 Nov; 34(11):3102-14. PubMed ID: 15368273
[TBL] [Abstract][Full Text] [Related]
13. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27.
Manickan E; Yu Z; Rouse RJ; Wire WS; Rouse BT
Viral Immunol; 1995; 8(2):53-61. PubMed ID: 8825290
[TBL] [Abstract][Full Text] [Related]
16. J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.
Taylor PR; Koski GK; Paustian CC; Bailey E; Cohen PA; Moore FB; Zimmerman DH; Rosenthal KS
Vaccine; 2010 Aug; 28(34):5533-42. PubMed ID: 20600501
[TBL] [Abstract][Full Text] [Related]
17. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
Liu XJ; Zhu MZ; Song GX; Xu YF; Liu HW; Wang S; Yang BL; Dong FT; Xu XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):67-72. PubMed ID: 15782496
[TBL] [Abstract][Full Text] [Related]
18. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins.
Nass PH; Elkins KL; Weir JP
J Infect Dis; 1998 Sep; 178(3):611-7. PubMed ID: 9728527
[TBL] [Abstract][Full Text] [Related]
19. Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option?
Noisakran S; Carr DJ
Immunol Res; 2001; 24(1):1-11. PubMed ID: 11485206
[TBL] [Abstract][Full Text] [Related]
20. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
